HRP980538A2 - Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate - Google Patents

Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

Info

Publication number
HRP980538A2
HRP980538A2 HR60/061,195A HRP980538A HRP980538A2 HR P980538 A2 HRP980538 A2 HR P980538A2 HR P980538 A HRP980538 A HR P980538A HR P980538 A2 HRP980538 A2 HR P980538A2
Authority
HR
Croatia
Prior art keywords
compound
formula
phenyl
alkyl
image
Prior art date
Application number
HR60/061,195A
Other languages
English (en)
Croatian (hr)
Inventor
Robert E Waltermire
Original Assignee
Robert E. Waltermire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert E. Waltermire filed Critical Robert E. Waltermire
Publication of HRP980538A2 publication Critical patent/HRP980538A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR60/061,195A 1997-10-06 1998-10-06 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate HRP980538A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6119597P 1997-10-06 1997-10-06

Publications (1)

Publication Number Publication Date
HRP980538A2 true HRP980538A2 (en) 1999-10-31

Family

ID=22034252

Family Applications (1)

Application Number Title Priority Date Filing Date
HR60/061,195A HRP980538A2 (en) 1997-10-06 1998-10-06 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

Country Status (19)

Country Link
US (2) US6218534B1 (et)
EP (1) EP1025092A2 (et)
JP (1) JP2001519335A (et)
KR (1) KR20010024403A (et)
CN (1) CN1273586A (et)
AR (1) AR017763A1 (et)
AU (1) AU9788198A (et)
BR (1) BR9815400A (et)
CA (1) CA2304513A1 (et)
EE (1) EE200000157A (et)
HR (1) HRP980538A2 (et)
HU (1) HUP0003933A3 (et)
IL (1) IL135470A0 (et)
NO (1) NO20001749L (et)
PL (1) PL340238A1 (et)
SK (1) SK4732000A3 (et)
TW (1) TW505649B (et)
WO (1) WO1999018085A2 (et)
ZA (1) ZA989099B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449111B2 (en) * 2003-07-30 2008-11-11 Arkema Inc. Resins containing ionic or ionizable groups with small domain sizes and improved conductivity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5530124A (en) 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5532356A (en) 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
US5998614A (en) * 1997-07-07 1999-12-07 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas using an alkali metal in liquid ammonia process

Also Published As

Publication number Publication date
EE200000157A (et) 2001-02-15
SK4732000A3 (en) 2001-03-12
US20010020093A1 (en) 2001-09-06
KR20010024403A (ko) 2001-03-26
WO1999018085A3 (en) 1999-06-24
AR017763A1 (es) 2001-10-24
NO20001749L (no) 2000-06-05
JP2001519335A (ja) 2001-10-23
BR9815400A (pt) 2001-09-25
HUP0003933A3 (en) 2001-12-28
US6452000B2 (en) 2002-09-17
PL340238A1 (en) 2001-01-29
TW505649B (en) 2002-10-11
EP1025092A2 (en) 2000-08-09
ZA989099B (en) 2000-04-06
CA2304513A1 (en) 1999-04-15
CN1273586A (zh) 2000-11-15
NO20001749D0 (no) 2000-04-05
US6218534B1 (en) 2001-04-17
HUP0003933A2 (hu) 2001-10-28
WO1999018085A2 (en) 1999-04-15
AU9788198A (en) 1999-04-27
IL135470A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
AU2008309411B2 (en) Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
CZ291626B6 (cs) Tricyklické sloučeniny, způsob výroby a použití
US5932726A (en) Asymmetric synthesis of benzoxazinones
HRP980192A2 (en) Asymmetric synthesis of benzoxazinones
HRP960258A2 (en) Method for preparing n,n'-disubstituted cyclic ureas
HRP980538A2 (en) Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
Ward et al. Synthesis of a quinolone library from ynones
EP2170840A1 (en) An improved process for preparing purine derivative
ES2529057T3 (es) Procedimientos para la hidrogenación de derivados de alcaloides opiáceos
KR20160118359A (ko) 2-(아미노 에틸옥시) 벤조산 유도체의 고리화에 의한 3,4-디히드로-1,4-벤족사제핀-5(2h)-온 유도체의 제조
Wylie et al. Synthesis of amino-substituted indoles using the Bartoli reaction
KR20210104833A (ko) 치환된 헤테로사이클 융합 감마-카르볼린 합성
Wu et al. Generation of cyclopenta [c] piperidines and pyrrolo [3, 4-c] piperidines—potential substance P antagonists—from adducts of cyclic dienophiles and 5-chloro-6-methyl-3-phenyl-2H-1, 4-oxazin-2-one
Yu et al. Cycloaddition of homophthalic anhydrides with aldehydes and ketones: A route to 3, 4-dihydroisocoumarin-4-carboxylic acid derivatives
MXPA00003328A (en) Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
HU182719B (en) Process for preparing basically substituted aralkyl-amino-alkyl-phenyl-acetonitriles
JPS59108748A (ja) 置換テトラヒドロナフタレン化合物
CZ20001127A3 (cs) Způsob výroby nesymetrických cyklických močovin přes monoacylované diaminové meziprodukty
JP4086258B2 (ja) N−アルケニルカルボン酸アミドの製法
CN115611904A (zh) 抗疼痛化合物及其制备方法
Liang et al. Synthesis of galanthamine analogs as acetylcholinesterase inhibitors via intramolecular heck cyclization
US5639890A (en) Preparation of N-akenylcarbamic esters
Saleh et al. Synthesis and 2, 7-functionalization of the bicyclic lactam 2-benzyloctahydropyrido [1, 2-a] pyrazin-6-one
Bunce et al. (±)‐2‐alkyl‐1, 2, 3, 4‐tetrahydroquinoline‐3‐carboxylic esters by a catalyst and pressure dependent tandem reduction‐reductive amination reaction
Ding et al. A new approach to the bicyclo [3.3. 1] nonane framework of huperzine A-like molecules via palladium-catalyzed intramolecular γ-arylation

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBI Application refused